These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8971005)

  • 1. Demonstration of binding of dengue virus envelope protein to target cells.
    Chen Y; Maguire T; Marks RM
    J Virol; 1996 Dec; 70(12):8765-72. PubMed ID: 8971005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.
    Chen Y; Maguire T; Hileman RE; Fromm JR; Esko JD; Linhardt RJ; Marks RM
    Nat Med; 1997 Aug; 3(8):866-71. PubMed ID: 9256277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
    Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.
    Hershkovitz O; Rosental B; Rosenberg LA; Navarro-Sanchez ME; Jivov S; Zilka A; Gershoni-Yahalom O; Brient-Litzler E; Bedouelle H; Ho JW; Campbell KS; Rager-Zisman B; Despres P; Porgador A
    J Immunol; 2009 Aug; 183(4):2610-21. PubMed ID: 19635919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J; Cheah CY; AbuBakar S
    Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection.
    Herchenröder O; Moosmayer D; Bock M; Pietschmann T; Rethwilm A; Bieniasz PD; McClure MO; Weis R; Schneider J
    Virology; 1999 Mar; 255(2):228-36. PubMed ID: 10069948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
    Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
    Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates.
    Dubin G; Basu S; Mallory DL; Basu M; Tal-Singer R; Friedman HM
    J Virol; 1994 Apr; 68(4):2478-85. PubMed ID: 7511171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
    Saokaew N; Poungpair O; Panya A; Tarasuk M; Sawasdee N; Limjindaporn T; Chaicumpa W; Yenchitsomanus P
    Lett Appl Microbiol; 2014 Mar; 58(3):270-7. PubMed ID: 24266517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system.
    Bielefeldt-Ohmann H; Beasley DW; Fitzpatrick DR; Aaskov JG
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2723-33. PubMed ID: 9367357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-activated human α2-macroglobulin interacts with the envelope protein of dengue virus and protects virions from temperature-induced inactivation through multivalent binding.
    Huerta V; Toledo P; Fleitas N; Martín A; Pupo D; Yero A; Sarría M; Sánchez A; Besada V; Ramos Y; Márquez G; Guirola O; Chinea G
    J Gen Virol; 2014 Dec; 95(Pt 12):2668-2676. PubMed ID: 25100798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
    Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
    Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding.
    Watterson D; Kobe B; Young PR
    J Gen Virol; 2012 Jan; 93(Pt 1):72-82. PubMed ID: 21957126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.
    Langevin C; Tuffereau C
    J Virol; 2002 Nov; 76(21):10756-65. PubMed ID: 12368318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
    Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.
    Erb SM; Butrapet S; Moss KJ; Luy BE; Childers T; Calvert AE; Silengo SJ; Roehrig JT; Huang CY; Blair CD
    Virology; 2010 Oct; 406(2):328-35. PubMed ID: 20708768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
    Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.
    de Parseval A; Elder JH
    J Virol; 2001 May; 75(10):4528-39. PubMed ID: 11312323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.
    Chu JJH; Rajamanonmani R; Li J; Bhuvanakantham R; Lescar J; Ng ML
    J Gen Virol; 2005 Feb; 86(Pt 2):405-412. PubMed ID: 15659760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.